Patents by Inventor Taylor Harding

Taylor Harding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TCR/BCR Profiling
    Publication number: 20230121729
    Abstract: This present disclosure relates to systems, methods, and compositions useful for profiling T cell receptor (TCR) and B cell receptor (BCR) repertoire using next-generation sequencing (NGS) methods. The present disclosure also relates to systems and methods for diagnosing, treating, or predicting infection, disease, medical conditions, therapeutic outcome, or therapeutic efficacy based on the TCR/BCR profile data from a subject in need thereof.
    Type: Application
    Filed: August 12, 2022
    Publication date: April 20, 2023
    Inventors: Jason Perera, Taylor Harding, Brittany Mineo, Aly A. Khan, Richard Blidner, Jenna L. Malinauskas
  • TCR/BCR profiling using enrichment with pools of capture probes
    Patent number: 11414700
    Abstract: Disclosed herein are systems, methods, and compositions useful for profiling T cell receptor (TCR) and B cell receptor (BCR) repertoire using next-generation sequencing (NGS) methods. In certain embodiments, the methods include enriching a sample for TCR/BCR RNA sequences, and determining the TCR/BCR profile of a subject using five different oligonucleotide pools. Also disclosed herein are systems and methods for diagnosing, treating, or predicting infection, disease, medical conditions, therapeutic outcome, or therapeutic efficacy based on the TCR/BCR profile data from a subject in need thereof.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: August 16, 2022
    Assignee: Tempus Labs, Inc.
    Inventors: Jason Perera, Taylor Harding, Brittany Mineo, Aly A. Khan, Richard Blidner, Jenna L. Malinauskas
  • TCR/BCR Profiling
    Publication number: 20210355533
    Abstract: This present disclosure relates to systems, methods, and compositions useful for profiling T cell receptor (TCR) and B cell receptor (BCR) repertoire using next-generation sequencing (NGS) methods. The present disclosure also relates to systems and methods for diagnosing, treating, or predicting infection, disease, medical conditions, therapeutic outcome, or therapeutic efficacy based on the TCR/BCR profile data from a subject in need thereof.
    Type: Application
    Filed: April 21, 2021
    Publication date: November 18, 2021
    Inventors: Jason Perera, Taylor Harding, Brittany Mineo, Aly A. Khan, Richard Blidner, Jenna L. Malinauskas